MedPath

Comparision of oral and intranasal routes for midazolam premedication in paediatric patients

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/08/055961
Lead Sponsor
Shaji P John
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Paediatric patients aged between 1-10 years scheduled for elective surgeries.

American Society of Anaesthesiologist (ASA) grade 1 and 2.

Exclusion Criteria

Children with central nervous system disorder, epilepsy, developmental delay, mental

retardation.

Known hypersensitivity and contraindication to drugs used.

History of significant cardiac, respiratory, renal, hepatic disease.

Patients having nasal infection, nasal pathology and taking any other sedative drugs.

Parental refusal.

Anticipated difficult airway.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To find out the level of sedation (sedation score) & acceptance of the route of administration of <br/ ><br>the drug between the two groups. <br/ ><br>To find out the ease of parental separation (separation score) between the two groups.Timepoint: Grades of sedation at - <br/ ><br>0 mins <br/ ><br>5 mins <br/ ><br>15 mins <br/ ><br>20 mins
Secondary Outcome Measures
NameTimeMethod
To assess hemodynamic stability, recovery characteristics (recovery score) & time taken to <br/ ><br>achieve satisfactory sedation between the two groups.Timepoint: Present or not present
© Copyright 2025. All Rights Reserved by MedPath